An appropriate inclusion of pre - and postmenopausal women
in early phase trials but also pregnant diabetic women and both elderly men and women in randomized controlled trials are necessary to guarantee high - quality research and healthcare for both sexes at all ages.
Early phase trials with anti-PD-L1 and anti-PD-1 antibodies have shown clinical activity in RCC and early biomarker assessment suggests PD - L1 tumor expression may influence response.
«This is
an early phase trial,» said Pandit - Taskar.
«Although still only in
an early phase trial, brigatinib is showing an objective response rate in approximately 70 percent of ALK - positive patients post-crizotinib and it's showing about a year of progression - free survival.
While this is still only interim data from
an early phase trial, this study is a positive result for Spark Therapeutics and Pfizer, as well as future patients.
The studios provide critical feedback for research study design and ensure that
early phase trials have the necessary levels of institutional support.